![]() |
Autoimmune Disorders |
Free Subscription
4 BMC Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Autoimmune Disorders is free of charge.
Spectral resolution and speech comprehension performance in noise in individuals
with multiple sclerosis.
BMC Neurol. 2025;25:257.
PubMed
Abstract available
A novel gene signature for forecasting time to next relapse in multiple sclerosis
using peripheral blood mononuclear cells.
BMC Neurol. 2025;25:261.
PubMed
Abstract available
Circulating inflammatory cytokines and the risk of myasthenia gravis: a
bidirectional Mendelian randomization study.
BMC Neurol. 2025;25:271.
PubMed
Abstract available
Development and validation of the antecedents affecting coping questionnaire in
patients with multiple sclerosis.
BMC Neurol. 2025;25:254.
PubMed
Abstract available
Pathogenic mechanisms of autoantibodies in neurological autoimmune diseases.
Curr Opin Immunol. 2025;95:102594.
PubMed
Abstract available
CD8(+)T cell exhaustion: the potential for treating autoimmune diseases.
Curr Opin Immunol. 2025;95:102600.
PubMed
Abstract available
Co-occurrence of Neuromyelitis Optica Spectrum Disorder and Idiopathic
Multicentric Castleman Disease Successfully Treated with Tocilizumab.
Intern Med. 2025;64:2073-2079.
PubMed
Abstract available
Stratifying patients by TNFSF13B genotype revealed increased flare and renal
flare risk, but a greater benefit from belimumab: a potential biomarker for
personalized treatment in systemic lupus erythematosus.
J Autoimmun. 2025;155:103455.
PubMed
Abstract available
Deciphering the role of IL-17D, its newly identified receptor CD93, and
IL-17D-CD93 axis in health and disease.
J Immunol. 2025;214:1113-1122.
PubMed
Abstract available
WDFY1-expressing follicular dendritic cells play a critical role in lupus
development in cGVHD mouse model.
J Immunol. 2025;214:1160-1172.
PubMed
Abstract available
Evolution and significance of neuronal surface autoantibodies after Japanese
encephalitis.
J Neuroimmunol. 2025;406:578671.
PubMed
Abstract available
Added value of spinal cord MRI in detecting active disease in non-relapsing
progressive multiple sclerosis patients.
J Neurol. 2025;272:482.
PubMed
Abstract available
Long-term effectiveness and safety of ocrelizumab: a single-centre real-world
study.
J Neurol. 2025;272:481.
PubMed
Abstract available
Clonidine for the management of crises in stiff-person syndrome.
J Neurol. 2025;272:485.
PubMed
Abstract available
Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barre
syndrome.
J Neurol. 2025;272:487.
PubMed
Abstract available
Therapeutic strategies targeting complement in myasthenia gravis patients.
J Neurol. 2025;272:489.
PubMed
Abstract available
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity
in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis
Cohort.
J Neurol. 2025;272:491.
PubMed
Abstract available
Identifying the State of Mental Health Care in Canadian Adults with Systemic
Lupus Erythematosus.
J Rheumatol. 2025 Jul 1:jrheum.2025-0089. doi: 10.3899/jrheum.2025-0089.
PubMed
Abstract available
Multivariable models to predict a diagnosis of Giant Cell Arteritis: systematic
review and meta-analysis.
J Rheumatol. 2025 Jul 1:jrheum.2022-1204. doi: 10.3899/jrheum.2022-1204.
PubMed
Abstract available
Prevalence, Risk Factors, and Outcomes of Chronic Kidney Disease in Systemic
Lupus Erythematosus Patients with and without Lupus Nephritis.
J Rheumatol. 2025 Jul 1:jrheum.2024-1087. doi: 10.3899/jrheum.2024-1087.
PubMed
Abstract available
The Risk and Time Course for Autoimmune Rheumatic Disease Development in Patients
With Raynaud Phenomenon.
J Rheumatol. 2025 Jul 1:jrheum.2024-0954. doi: 10.3899/jrheum.2024-0954.
PubMed
Comparison of Lupus Nephritis Onset Before and After Age 50: Impact on
Presentation and Outcomes in an Inception Cohort.
J Rheumatol. 2025 Jul 1:jrheum.2024-1278. doi: 10.3899/jrheum.2024-1278.
PubMed
Abstract available
Comparative Analysis of Damage Accrual in Lupus Nephritis Stratified by
Biological Sex.
J Rheumatol. 2025 Jul 1:jrheum.2025-0302. doi: 10.3899/jrheum.2025-0302.
PubMed
Abstract available
Antinuclear Antibody Multiplex Utilization Across a Large Federal Hospital
System: An Investigation of Ordering Practices and Rheumatologic Outcomes.
J Rheumatol. 2025;52:721-727.
PubMed
Abstract available
Quantifying association of early proteinuria and estimated glomerular filtration
rate changes with long-term kidney failure in C3 glomerulopathy and
immune-complex membranous proliferative glomerulonephritis using the United
Kingdom RaDaR Registry.
Kidney Int. 2025 Jun 27:S0085-2538(25)00491-0. doi: 10.1016/j.kint.2025.
PubMed
Abstract available
Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the
Efficacy and Safety of Felzartamab for IgA Nephropathy.
Kidney Int. 2025 Jun 26:S0085-2538(25)00488-0. doi: 10.1016/j.kint.2025.
PubMed
Abstract available
Neural networks to estimate multiple sclerosis disability and predict progression
using routinely collected healthcare data.
Mult Scler. 2025 Jul 3:13524585251347513. doi: 10.1177/13524585251347513.
PubMed
Abstract available
The importance of patient-reported outcomes: A call for their integration in the
routine care of patients with multiple sclerosis.
Mult Scler. 2025 Jun 29:13524585251349354. doi: 10.1177/13524585251349354.
PubMed
Abstract available
Understanding Racial and Ethnic Disparities in Myasthenia Gravis Outcomes:
EXPLORE-MG Registry Experience.
Neurol Clin Pract. 2025;15:e200503.
PubMed
Abstract available
Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the
Phase 3 OCARINA II Study.
Neurology. 2025;105:e213909.
PubMed
Exploring the relationship between self-care agency and quality of life in adults
with diabetes: A cross-sectional study.
PLoS One. 2025;20:e0326783.
PubMed
Abstract available
Thank you for your interest in scientific medicine.